Article
Intranasal "painless" human Nerve Growth Factor [corrected] slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice.
PloS one - 1 Jan 2012
Capsoni Simona, Marinelli Sara, Ceci Marcello, Vignone Domenico, Amato Gianluca, Malerba Francesca, Paoletti Francesca, Meli Giovanni, Viegi Alessandro, Pavone Flaminia, Cattaneo Antonino
Abstract excerpt
Nerve Growth Factor (NGF) is being considered as a therapeutic candidate for Alzheimer's disease (AD) treatment but the clinical application is hindered by its potent pro-nociceptive activity. Thus, to reduce systemic exposure that would induce pain, in recent clinical studies NGF was administered through an invasive intracerebral gene-therapy approach. Our group demonstrated the feasibility of a non-invasive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
